# Harrow to Present at Two Investor Conferences in December
Canonical URL: https://biopharmsignal.com/news/HROW/harrow-to-present-at-two-investor-conferences-in-december-c6ad2c86
Ticker: HROW
Company: Harrow, Inc.
Source: Harrow, Inc.
Published: 2025-11-24 12:00 EST
## Summary

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North...

## Article Body
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following two investor conferences in December:

BTIG 5 th Annual Ophthalmology Day (Virtual) Format: Fireside chat Date/Time: Monday, December 1, 2025, at 8:30 AM EST

Piper Sandler 37 th Annual Healthcare Conference (New York, NY) Format: Fireside chat Date/Time: Tuesday, December 2, 2025, at 3:00 PM EST

The fireside chat at Piper Sandler will be webcast live and can be found on the Event’s page on the Company’s website . A replay will be available for approximately 90 days following the event.

About Harrow Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com.

Contacts: Mike Biega Vice President of Investor Relations and Communications mbiega@harrowinc.com 617-913-8890
## Recent Company News
- 2026-07-27 11:00 EST — [Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026](https://biopharmsignal.com/news/HROW/harrow-to-report-second-quarter-2026-financial-results-after-market-close-on-aug-38f34b84) — Source: Harrow, Inc.
- 2026-07-20 12:00 EST — [Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026](https://biopharmsignal.com/news/HROW/samsung-bioepis-and-harrow-present-interim-data-from-a-large-scale-post-marketin-f2b635bb) — Source: Harrow, Inc.
- 2026-07-20 11:00 EST — [Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting](https://biopharmsignal.com/news/HROW/harrow-highlights-growing-clinical-evidence-supporting-iheezo-and-byooviz-at-asr-8b380ee4) — Source: Harrow, Inc.
- 2026-07-01 11:00 EST — [Harrow Announces Commercial Launch of BYOOVIZ® in the United States](https://biopharmsignal.com/news/HROW/harrow-announces-commercial-launch-of-byooviz-in-the-united-states-234ff9de) — Source: Harrow, Inc.
- 2026-06-10 11:00 EST — [Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare](https://biopharmsignal.com/news/HROW/harrow-re-launches-verkazia-cyclosporine-ophthalmic-emulsion-0-1-for-vernal-kera-d7c7e3c9) — Source: Harrow, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)